More impressive results emerged from the STEP 1 extension study, where 69% of semaglutide-treated participants achieved at least 10% weight loss, and 50% achieved at least 15% weight loss
Conclusions In summary, this study provides comprehensive mechanistic insights into how Retatrutide, a triple agonist of the GIP, GLP-1, and glucagon receptors, exerts potent anti-obesity and metabolic benefits through coordinated molecular and metabolic remodeling of adipose tissue
Andra Picincu, CN, CPT Author Andra Picincu is a certified nutritionist, personal trainer, and content writer with more than 15 years of experience
Fermented foods that support GLP-1: Plain Greek yogurt (live cultures) Kefir (dairy or water-based) Sauerkraut and kimchi (raw, unpasteurized) Miso and tempeh Kombucha (low sugar varieties) Ready to Reset Your Metabolic Health
Who Should Consider Prescription GLP-1 Options Over OTC Alternatives Individuals with BMI over 27, metabolic syndrome, prediabetes, or type 2 diabetes have the strongest clinical evidence supporting prescription GLP-1 therapy
The clinical significance of this improvement becomes clearer when translated to real world outcomes